DK0571420T4 - Mycobakteriepolypeptider og for disse kodende nucleinsyrer til diagnose og behandling af tuberkulose - Google Patents

Mycobakteriepolypeptider og for disse kodende nucleinsyrer til diagnose og behandling af tuberkulose

Info

Publication number
DK0571420T4
DK0571420T4 DK92903939T DK92903939T DK0571420T4 DK 0571420 T4 DK0571420 T4 DK 0571420T4 DK 92903939 T DK92903939 T DK 92903939T DK 92903939 T DK92903939 T DK 92903939T DK 0571420 T4 DK0571420 T4 DK 0571420T4
Authority
DK
Denmark
Prior art keywords
nucleic acids
tuberculosis
diagnosis
treatment
coding nucleic
Prior art date
Application number
DK92903939T
Other languages
Danish (da)
English (en)
Other versions
DK0571420T3 (da
Inventor
Jean Content
Wit Lucas De
Bruyn Jacqueline De
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8208544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0571420(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of DK0571420T3 publication Critical patent/DK0571420T3/da
Application granted granted Critical
Publication of DK0571420T4 publication Critical patent/DK0571420T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92903939T 1991-02-14 1992-02-07 Mycobakteriepolypeptider og for disse kodende nucleinsyrer til diagnose og behandling af tuberkulose DK0571420T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91400388A EP0499003A1 (fr) 1991-02-14 1991-02-14 Polypeptides et peptides, en particulier polypeptides et peptides recombinants, acides nucléiques les encodantes, et leur utilisation pour le diagnostic de la tuberculose

Publications (2)

Publication Number Publication Date
DK0571420T3 DK0571420T3 (da) 1997-12-29
DK0571420T4 true DK0571420T4 (da) 2005-06-20

Family

ID=8208544

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92903939T DK0571420T4 (da) 1991-02-14 1992-02-07 Mycobakteriepolypeptider og for disse kodende nucleinsyrer til diagnose og behandling af tuberkulose

Country Status (12)

Country Link
US (2) US5955356A (fr)
EP (2) EP0499003A1 (fr)
JP (1) JPH06504909A (fr)
AT (1) ATE153697T1 (fr)
AU (1) AU659822B2 (fr)
CA (1) CA2104111C (fr)
DE (1) DE69220042T3 (fr)
DK (1) DK0571420T4 (fr)
ES (1) ES2103928T5 (fr)
GR (1) GR3024408T3 (fr)
IL (1) IL100938A0 (fr)
WO (1) WO1992014823A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
AU1097795A (en) * 1993-11-23 1995-06-13 Regents Of The University Of California, The Abundant extracellular products and methods for their production and use
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
WO1996005223A1 (fr) * 1994-08-12 1996-02-22 The Regents Of The University Of California Produits extracellulaires abondants, procedes pour les produire et leur utilisation
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5935568A (en) * 1995-05-18 1999-08-10 National Jewish Medical & Research Center Gene therapy for effector cell regulation
AU6260796A (en) * 1995-06-07 1996-12-30 National Jewish Center For Immunology And Respiratory Medicine Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
GB9714242D0 (en) * 1997-07-07 1997-09-10 Mini Agriculture & Fisheries Glycosylation peptides
US6291190B1 (en) * 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
WO2000073345A2 (fr) * 1999-05-28 2000-12-07 Promega Corporation Anticorps specifiques des polypeptides mycobacteriens et leurs utilisations
GB0006693D0 (en) * 2000-03-20 2000-05-10 Glaxo Group Ltd Vaccine
AU2001271963A1 (en) * 2000-07-10 2002-01-21 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
AU2003210818A1 (en) * 2002-02-01 2003-09-02 Cornell Research Foundation, Inc. Compositions and methods for treatment of infectious and inflammatory diseases
US20050267025A1 (en) * 2002-02-01 2005-12-01 Ho John L Compositions and methods for treatment of infectious and inflammatory diseases
SG159554A1 (en) 2004-11-16 2010-03-30 Crucell Holland Bv Multivalent vaccines comprising recombinant viral vectors
US20120321656A1 (en) * 2011-06-20 2012-12-20 Matthias Rath Oligopeptides and their use for treating infectious diseases
US20140349320A1 (en) * 2011-12-15 2014-11-27 The Trustees Of The University Of Pennsylvania Using Adaptive Immunity to Detect Drug Resistance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264550A (en) * 1985-04-15 1993-11-23 Scios Nova Inc. Human anti-inflammatory phospholipase inhibitor protein
US4689397A (en) * 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
EP0486495A1 (fr) * 1989-03-08 1992-05-27 Commonwealth Scientific And Industrial Research Organisation Systeme d'expression pour des actinomycetes et des organismes apparentes
FR2645878B1 (fr) * 1989-04-17 1994-02-25 Institut Nal Sante Recherc Medic Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes

Also Published As

Publication number Publication date
ES2103928T5 (es) 2005-09-01
EP0571420B2 (fr) 2005-03-16
EP0571420B1 (fr) 1997-05-28
EP0499003A1 (fr) 1992-08-19
AU659822B2 (en) 1995-06-01
ATE153697T1 (de) 1997-06-15
DE69220042T2 (de) 1997-12-11
US5955356A (en) 1999-09-21
DK0571420T3 (da) 1997-12-29
CA2104111C (fr) 2008-01-08
EP0571420A1 (fr) 1993-12-01
AU1223492A (en) 1992-09-15
US6638511B1 (en) 2003-10-28
DE69220042T3 (de) 2005-12-01
JPH06504909A (ja) 1994-06-09
GR3024408T3 (en) 1997-11-28
WO1992014823A1 (fr) 1992-09-03
DE69220042D1 (de) 1997-07-03
IL100938A0 (en) 1992-11-15
CA2104111A1 (fr) 1992-08-15
ES2103928T3 (es) 1997-10-01

Similar Documents

Publication Publication Date Title
DK0571420T3 (da) Mycobakteriepolypeptider og for disse kodende nucleinsyrer til diagnose og behandling af tuberkulose
ATE241014T2 (de) Hiv-2 varianten
DK0776209T3 (da) Polynukleinsyrer og proteiner fra et porcin reproduktiv og respiratorisk syndrom-virus og anvendelser deraf
DK1047784T3 (da) Neissera meningitidis-antigener
DK0650527T3 (da) Forbedring af Borrelia burgdorferidiagnose og -profylakse
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
AU4691589A (en) Feline infectious peritonitis virus diagnostic tools
IL95742A0 (en) Recombinant polypeptides and peptides,nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
DE69018926D1 (de) Vakzine gegen Bordetella.
ATE89155T1 (de) Geraet zur wiederherstellung eines gliedes.
DE3850641D1 (de) Struktur zur Versiegelung eines elektrostriktiven Elements.
DK161487D0 (da) Alfa-interferon-analoge og fremgangsmaade til fremstilling deraf samt udtrykkelsesvektorer og vaertsorganismer til anvendelse ved fremgangsmaaden.
NO882113L (no) Substituerte vinylcefalosporiner, fremgangsmaate til deresfremstilling, og deres anvendelse som legemiddel.
JPS6456695A (en) Peptide
DK130290D0 (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
DK312989D0 (da) 1,4-dihydropyridin-threonin-derivater og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse samt mellemprodukter til fremstillingen
ATE220103T1 (de) Plasmide aus lactobacillus delbrueckii sp.
IT8722869V0 (it) Dispositivo perfezionato per l'abbronzatura artificiale integrale o parziale.
BR0107799A (pt) Proteìna de interação de wt1 wtip